Transmedics.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 38
What's happening
One to three months ago
-
SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.Some support1 report1 development inside
-
Hernandez is named as the Chief Financial Officer (CFO) of TransMedics.Some support1 report
-
Transmedics is headquartered in Andover, MA.Some support4 reports
-
An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.Some support1 report
-
Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.Some support1 report
-
Nvidia and Transmedics are being discussed in the context of investment signals.Some support2 reports
Gone quiet
No new reports in 90+ days-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.Some support1 report
-
OrganOx Metra removed its air transport warning from its label.Speculative1 report
-
A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.Some support1 report
-
Veracyte and Transmedics operate within the same molecular diagnostic industry.Some support1 report1 development inside
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.Some support1 report
-
Transmedics entered international markets via a facility in Italy.Some support1 report
-
FDA approval is identified as a key regulatory catalyst for Transmedics.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Transmedics this week
News at the entities that move Transmedics most-
OCS StructuralOCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.Moves Transmedics
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Transmedics
-
London Health Sciences Centre StructuralDave Nagpal is now the medical co-director of the transplant program at the London Health Sciences Centre.Moves Transmedics
-
Italy StructuralFast food chains are rapidly expanding across Italy.Moves Transmedics
-
Needham & Company Mentioned togetherSEC is overseeing public offering filings involving Broadridge Financial Solutions.Moves Transmedics
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Transmedics
Connections
The 17 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
OCS Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
FDA Structural
Transmedics' products depend on FDA regulatory approvals and oversight for market operation.
-
Nasdaq Structural
Transmedics conducts its trading business on the Nasdaq stock exchange platform.
-
Italy Structural
Transmedics is establishing and utilizing a manufacturing plant in Italy.
-
London Health Sciences Centre Structural
LHS Centre provides the necessary Organ Care System for Transmedics' transplant operations.
-
Hernandez Structural
Hernandez holds the position of Chief Financial Officer at Transmedics.
-
SEC Structural
Transmedics operates under the regulatory oversight of the SEC, requiring formal financial disclosures.
-
Brian Johnston Transactional
Brian Johnston holds the role of Investor Contact for Transmedics.
Show all 17 connections
-
SoFi Mentioned together
Both SoFi and Transmedics are mentioned in the same context as investment opportunities.
-
Europe Shared context
Transmedics is conducting market expansion and establishing transplant networks within the European geographical context.
-
Andover Shared context
Transmedics is headquartered in Andover, Massachusetts.
-
Nvidia Mentioned together
Nvidia and Transmedics are co-mentioned as examples of investment opportunities and growth signals.
-
Needham & Company Mentioned together
Needham & Company provides analyst ratings and target price cuts for Transmedics.
-
Andover Shared context
TransMedics is headquartered in Andover, Massachusetts.
-
Massachusetts Shared context
Transmedics is headquartered in the state of Massachusetts.
-
One World Trade Center Shared context
The entities are linked in the context of a corporate governance investigation.
-
Boston Shared context
TransMedics is scheduled to participate in a conference held in Boston.
History
Events by the month they beganAugust 2026
1 eventJuly 2026
4 events- SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.
- An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.
- Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.
- Nvidia and Transmedics are being discussed in the context of investment signals.
June 2026
11 events- Transmedics is headquartered in Andover, MA.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.
- OrganOx Metra removed its air transport warning from its label.
- A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.
- Veracyte and Transmedics operate within the same molecular diagnostic industry.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.
- Transmedics entered international markets via a facility in Italy.
- FDA approval is identified as a key regulatory catalyst for Transmedics.